UNSPSC 51282115: Oximonam

This classification denotes a beta-lactam antibiotic with the molecular formula C12H15N5O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 482M43SL0K, chemically known as acetic acid, ((3-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-methyl-4-oxo-1-azetidinyl)oxy)-, (2s-(2alpha,3beta(z)))- but generally known as oximonam, which bears US NIH Compound Identifier 9571070. European Medicines Agency schedules Oximonam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09531MIG.

UNSPSC 51282115 Oximonam is a Commodity code that in practice covers pharmaceutical products procured by state and local health agencies, though recent activity under this specific code is sparse and does not align cleanly with oximonam's nominal scope. The two recent opportunities tagged to this code reflect state and local procurement of antibiotics (doxycycline and ciprofloxacin) and emergency-response pharmaceuticals (naloxone) through competitive bidding processes. Issuing bodies include state health departments and county public health authorities. The Illinois Department of Public Health procures pharmaceutical inventory through cooperative purchasing consortiums (MMCAP Infuse), while Seminole County, Florida procures naloxone and drug deactivation systems directly for community health support.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health completed an Invitation for Bid in August 2026 for antibiotic tablet supplies through the MMCAP Infuse piggyback vehicle, awarding Chartwell Rx LLC a three-year contract worth $2,999,999.11 for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets. Seminole County released an IFB in June 2026 (response deadline July 26, 2023 per source) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract carries a two-year initial term with one-year renewal option. Neither opportunity specified set-asides or preference programs. The code shows limited recent state and local posting activity; confirm whether oximonam procurement occurs under a different UNSPSC code or through emergency-supply relationships not reflected in open bidding records.